Neutrophil to lymphocytes ratio in deep infiltrating endometriosis as a new toll for clinical management

Mattia Dominoni,Marianna Francesca Pasquali,Valentina Musacchi,Annalisa De Silvestri,Matteo Mauri,Virginia Valeria Ferretti,Barbara Gardella

DOI: https://doi.org/10.1038/s41598-024-58115-6

IF: 4.6

2024-03-31

Scientific Reports

Abstract:Several mechanisms, including altered local and systemic immune system, apoptosis, and new angiogenesis, are responsible for the development and progression of endometriosis. Over the years many markers have been studied, like CA 125 and, recently, neutrophil-to-lymphocyte ratio (NLR). This tool is cost-effectiveness and non-invasiveness as a marker of systemic inflammatory diseases. The aim of this study is to assess the role of NLR in the real-life management of patients with endometriosis in order to evaluate the possible association between this value and symptoms. We performed a retrospective analysis of 199 premenopausal women affected by endometriosis, from January 2013 to December 2020, evaluating the characteristics of disease, the symptoms and the NLR. Analyzing the neutrophiles, the mean ± SD value was 6.1 ± 4.5 × 10 3 /ul, while for lymphocytes mean ± SD value was 1.8 ± 0.7.NLR was categorized according to its median value (> 2.62 vs ≤ 2.62). The comparison between NLR values and CA 125, endometriosis stage, dysmenorrhea and presence of chronic pelvic pain, adjusting for previous therapy did not find a significant association. An interesting result, although not significant, was the association between NLR and chronic pelvic pain (OR = 1.9). In the sub-group of patients without previous therapy this association is even stronger (OR = 4.8, 95% CI 0.5–50.2, p = 0.190). The link between NLR and chronic pelvic pain can provide a further hint to the clinician even when taking symptoms into account to develop a particular therapeutic treatment related to the various expressions of NLR. Finally, NLR may enable the creation of customized follow-up protocols that divide patients into high- and low-risk categories for endometriosis recurrence.

multidisciplinary sciences

What problem does this paper attempt to address?

This paper aims to evaluate the role of the neutrophil-to-lymphocyte ratio (NLR) in the actual clinical management of patients with endometriosis, particularly exploring the possible association between NLR values and symptoms. Endometriosis is a common chronic inflammatory disease that affects women of reproductive age, potentially leading to infertility and pelvic pain, severely impacting the quality of life of patients. Currently, many markers have been studied for the diagnosis of endometriosis, such as CA 125, but the sensitivity and specificity of these markers are limited. NLR, as a cost-effective and non-invasive marker of systemic inflammatory diseases, warrants further exploration in the context of endometriosis.

By retrospectively analyzing data from 199 premenopausal women with endometriosis who were examined at the Obstetrics and Gynecology Department of the San Matteo Foundation Hospital in Pavia, Italy, from January 2013 to December 2020, researchers assessed the relationship between NLR values and endometriosis-related symptoms and clinical staging. Although the study did not find a significant association between NLR and CA 125, endometriosis staging, or dysmenorrhea, a stronger association was observed between NLR and chronic pelvic pain in the untreated patient subgroup (OR = 4.8, 95% CI 0.5–50.2, p = 0.190). This finding suggests that NLR may serve as a reference indicator for clinicians when considering symptoms to formulate specific treatment plans, helping to customize follow-up protocols based on different NLR expressions, categorizing patients into high-risk and low-risk recurrence groups, thereby optimizing the management and treatment of endometriosis.